Carillon Tower Advisers’s Merck MRK Stock Holding History

Carillon Tower Advisers’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$20.3M	Hold	259,649	–	–	0.12%	239
2020 Q3	$20.6M	Sell	259,649 -61,458	-19%	-$4.81M	0.27%	136
2020 Q2	$23.7M	Sell	321,107 -5,073	-2%	-$382K	0.18%	164
2020 Q1	$23.2M	Sell	326,180 -23,844	-7%	-$1.87M	0.23%	151
2019 Q4	$30.4M	Sell	350,024 -12,145	-3%	-$998K	0.2%	177
2019 Q3	$29.1M	Sell	362,169 -57,854	-14%	-$4.64M	0.2%	168
2019 Q2	$33.6M	Buy	420,023 +11,365	+3%	+$870K	0.23%	150
2019 Q1	$32.4M	Buy	408,658 +150,715	+58%	+$11.3M	0.23%	162
2018 Q4	$18.8M	Buy	257,943 +18,971	+8%	+$1.34M	0.16%	226
2018 Q3	$16.2M	Sell	238,972 -109,811	-31%	-$7M	0.12%	264
2018 Q2	$20.2M	Buy	348,783 +100,834	+41%	+$5.69M	0.16%	214
2018 Q1	$12.6M	Sell	247,949 -9,839	-4%	-$531K	0.1%	272
2017 Q4	$13.8M	Buy	+257,788	New	+$14.3M	0.15%	198

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Carillon Tower Advisers's MRK Position: Q4 2020 in Review

Carillon Tower Advisers held its Merck (MRK) position steady in Q4 2020 at 259,649 shares worth $20.3M. The position accounts for 0.12% of the portfolio, ranked #239.

Carillon Tower Advisers first reported a position in MRK in Q4 2017 and has held it in 13 quarters since. The position peaked at $33.6M in Q2 2019. 2,709 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

Carillon Tower Advisers held 259,649 shares of Merck worth $20.3M as of Q4 2020.
Carillon Tower Advisers left its Merck share count unchanged in Q4 2020.
Merck made up 0.12% of Carillon Tower Advisers's portfolio in Q4 2020, its #239 holding.
Carillon Tower Advisers first reported a position in Merck in Q4 2017 and has held it in 13 quarters since.
Carillon Tower Advisers's Merck position peaked at $33.6M in Q2 2019.
2,709 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.